Skip to content
10-Q

Quarterly Report

RESOLUTE ONCOLOGY INC

0001038838-13-000234

← back to feed
Filed
May 17, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 13, 2013 40.39M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$881.53K
Operating Cash Flow Q1 2013 · Mar 31, 2013 $252.62K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $933.87K
Cash And Equivalents Q1 2013 · Dec 31, 2012 $1.08M
Stockholders Equity Q1 2013 · Mar 31, 2013 $1.22M
Stockholders Equity Q1 2013 · Dec 31, 2012 −$71.92K
Current Liabilities Q1 2013 · Mar 31, 2013 $1.1M
Current Liabilities Q1 2013 · Dec 31, 2012 $1.79M
Total Liabilities Q1 2013 · Mar 31, 2013 $1.1M
Total Liabilities Q1 2013 · Dec 31, 2012 $1.79M
Current Assets Q1 2013 · Mar 31, 2013 $2.32M
Current Assets Q1 2013 · Dec 31, 2012 $1.72M
Total Assets Q1 2013 · Mar 31, 2013 $2.32M
Total Assets Q1 2013 · Dec 31, 2012 $1.72M
Net Income Q1 2013 · Mar 31, 2013 −$193.58K
Net Income Q1 2013 · Mar 31, 2013 −$300.49K
Operating Income Q1 2013 · Mar 31, 2013 −$193.15K
Operating Income Q1 2013 · Mar 31, 2013 −$298.94K
Operating Income Q1 2013 · Mar 31, 2012 −$16.51K